Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled time : 14:00 source : Www.ampiopharma.com save search
AMPIO PHARMACEUTICALS ANNOUNCES PRICING OF $22.5 MILLION REGISTERED DIRECT OFFERING
Published: 2021-12-13 (Crawled : 14:00) - ampiopharma.com
AMPE | $0.286 0.0% 8K
|
Health Technology
|
| O: -3.66%
H: 0.0%
C: 0.0%
offering als
Ampio Pharmaceuticals Announces Top-line Results from AP-013 Phase III Study of Ampion in Adult Patients Suffering from Severe Osteoarthritis of the Knee (OAK)
Published: 2021-09-15 (Crawled : 14:00) - ampiopharma.com
AMPE | $0.286 0.0% 8K
|
Health Technology
|
| O: 3.47%
H: 22.82%
C: 14.77%
results osteoarthritis topline ap-013
Ampio Pharmaceuticals Announces Important New Research Manuscript on Anti-Inflammatory Mode of Action
Published: 2021-08-13 (Crawled : 14:00) - ampiopharma.com
AMPE | $0.286 0.0% 8K
|
Health Technology
|
| O: -3.36%
H: 0.0%
C: 0.0%
research
Ampio Pharmaceuticals to Present at the American College of Toxicology 42nd Annual Meeting
Published: 2021-07-29 (Crawled : 14:00) - ampiopharma.com
AMPE | $0.286 0.0% 8K
|
Health Technology
|
| O: -1.41%
H: 4.29%
C: 2.14%
Ampio Pharmaceuticals to Present at the 14th International Congress on Systemic Lupus Erythematosus (LUPUS 2021) & 6th International Congress on Controversies in Rheumatology and Autoimmunity (CORA)
Published: 2021-07-28 (Crawled : 14:00) - ampiopharma.com
AMPE | $0.286 0.0% 8K
|
Health Technology
|
| O: -2.24%
H: 8.78%
C: 8.4%
autoimmunity lupus
Ampio Pharmaceuticals, Inc. to Join the Russell 2000® Index and Russell 3000® Index
Published: 2021-06-18 (Crawled : 14:00) - ampiopharma.com
AMPE | $0.286 0.0% 8K
|
Health Technology
|
| O: -0.56%
H: 5.62%
C: 5.62%
Ampio Pharmaceuticals to Present Poster at the International Society for Aerosols in Medicine (ISAM) 23rd International Congress
Published: 2021-05-21 (Crawled : 14:00) - ampiopharma.com
AMPE | $0.286 0.0% 8K
|
Health Technology
|
| O: 1.03%
H: 1.52%
C: -0.51%
Ampio Pharmaceuticals Receives Investigational Review Board Approval for its Phase I Long COVID-19 Trial (AP-018)
Published: 2021-05-10 (Crawled : 14:00) - ampiopharma.com
AMPE | $0.286 0.0% 8K
|
Health Technology
|
| O: 0.0%
H: 3.78%
C: 1.62%
covid trial approval ap-013
Ampion™ Reduces All-cause Mortality in COVID-19 Respiratory Distress by Nearly 80%
Published: 2021-04-27 (Crawled : 14:00) - ampiopharma.com
AMPE | $0.286 0.0% 8K
|
Health Technology
|
| O: 2.14%
H: 4.97%
C: 1.05%
covid respiratory covid-19
Ampio Pharmaceuticals Provides Updates on Clinical Programs for Ampion™ in Osteoarthritis and COVID-19
Published: 2021-04-27 (Crawled : 14:00) - ampiopharma.com
AMPE | $0.286 0.0% 8K
|
Health Technology
|
| O: 2.14%
H: 4.97%
C: 1.05%
covid osteoarthritis covid-19
Research Shows Ampion™ Gene Regulation Mimics the Anti-Inflammatory Effects of Steroids, but without Adverse Effects
Published: 2021-04-19 (Crawled : 14:00) - ampiopharma.com
AMPE | $0.286 0.0% 8K
|
Health Technology
|
| O: -3.18%
H: 5.26%
C: 3.29%
research
Ampio Pharmaceuticals to Present at the International Society for Aerosols in Medicine (ISAM) 23rd International Congress
Published: 2021-03-29 (Crawled : 14:00) - ampiopharma.com
AMPE | $0.286 0.0% 8K
|
Health Technology
|
| O: 2.41%
H: 0.0%
C: -5.29%
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.